The process of drug development in pediatric oncology: a review of basic principals and a look into the future (original) (raw)
Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse
Rajeev Menon
The Journal of Clinical Pharmacology, 2018
View PDFchevron_right
Children's clinical cancer trials: what needs to change to allow children access to new cancer drugs?
Lucas Moreno
Expert review of clinical pharmacology, 2015
View PDFchevron_right
Pediatric Oncology: Regulatory Initiatives
Steven Hirschfeld
The Oncologist, 2000
View PDFchevron_right
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective
Lucas Moreno
Nature reviews. Clinical oncology, 2017
View PDFchevron_right
Clinical Trials in Paediatric Oncology
R. Serreau
Thérapie, 2003
View PDFchevron_right
Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New Initiatives
Steven Hirschfeld
Journal of Clinical Oncology, 2003
View PDFchevron_right
The role of the ‘innovative therapies for children with cancer’ (ITCC) European consortium
Riccardo Riccardi
Cancer Treatment Reviews, 2010
View PDFchevron_right
Testing of new agents in childhood cancer preclinical models: meeting summary
Glenn Merlino
Clinical cancer research : an official journal of the American Association for Cancer Research, 2002
View PDFchevron_right
Predictors of Success of Phase II Pediatric Oncology Clinical Trials
Murray Norris
The Oncologist
View PDFchevron_right
Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement
SuSHiL KuMar
Expert opinion on drug discovery, 2012
View PDFchevron_right
Enhancing the Pediatric Drug Development Framework to Deliver Better Pediatric Therapies Tomorrow
Christina Bucci Rechtweg
Clinical Therapeutics
View PDFchevron_right
Challenges in prescribing drugs for children with cancer
K. Pritchard-jones, Paolo Paolucci
The Lancet Oncology, 2008
View PDFchevron_right
ACCELERATE – Five years accelerating cancer drug development for children and adolescents
Pam Kearns
European Journal of Cancer, 2022
View PDFchevron_right
Food and Drug Administration Center for Drug Evaluation and Research SUMMARY MINUTES OF THE CDER PEDIATRIC ONCOLOGY SUBCOMMITTEE OF THE ONCOLOGIC DRUGS ADVISORY COMMITTEE
Karen Weiss
2000
View PDFchevron_right
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium
Lucas Moreno
European journal of cancer (Oxford, England : 1990), 2017
View PDFchevron_right
Challenging issues in pediatric oncology
Amar Gajjar
Nature Reviews Clinical Oncology, 2011
View PDFchevron_right
Pediatric Drug Development: Challenges and Opportunities
Cesare Spadoni
Current Therapeutic Research, 2018
View PDFchevron_right
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Christopher Copland
European Journal of Cancer, 2019
View PDFchevron_right
Perspectives on Pediatric Drug Development
Gregory Knipp
Revista Mexicana De Ciencias Farmaceuticas, 2012
View PDFchevron_right
Design and conduct of early phase drug studies in children: challenges and opportunities
Michael Rieder
British Journal of Clinical Pharmacology, 2016
View PDFchevron_right
Therapy concepts in the context of precision medicine for pediatric malignancies—children are not adults
Elisabeth Salzer
memo - Magazine of European Medical Oncology
View PDFchevron_right
Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group
Ambuj Kumar
British Medical Journal, 2005
View PDFchevron_right
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas
Vickie Buenger
European Journal of Cancer
View PDFchevron_right
Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis
Mateusz Blukacz
Targeted Oncology, 2021
View PDFchevron_right
A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults’ trials
AndrÉ Baruchel
European Journal of Cancer, 2013
View PDFchevron_right
Perspectives in pediatric clinical trials: a review
Kalpesh Gawand
International Journal of Clinical Trials, 2016
View PDFchevron_right
ACCELERATE and EMA Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children Authors
Mahdi Farhan
2019
View PDFchevron_right